JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nowak, T.
Right arrow Articles by Mildvan, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nowak, T.
Right arrow Articles by Mildvan, A. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stereoselective Interactions of Phosphoenolpyruvate Analogues with Phosphoenolpyruvate-utilizing Enzymes

Thomas Nowak 1 and Albert S. Mildvan 1

From the 1 From The Institute for Cancer Research, Philadelphia, Pennsylvania 19111

The optically pure d and l isomers of 2-phospholactate were synthesized by phosphorylation of the appropriate lactic acids. The interactions of these analogues and of phosphoglycolate with several enzymes that catalyze reactions of phosphoenolpyruvate were examined by kinetics and by direct binding studies measuring the longitudinal relaxation rate of water protons.

With pyruvate kinase, the Ki of d-phospholactate (21 µm) and of phosphoglycolate (52 µm) agree with the Km of phosphoenolpyruvate (26 µm), while the Ki of l-phospholactate (380 µm) is 18-fold greater. This difference in affinity is confirmed in the direct binding studies. The enhancement of the ternary pyruvate kinase-Mn-inhibitor complex of d-phospholactate (egrt = 1.9) and of phosphoglycolate (egrt = 1.7) agree with that of phosphoenolpyruvate (egrt = 2.2), but differs from that of l-phospholactate (egrt = 3.8), indicating a structural difference in this latter metal bridge complex.

With enolase, the inhibition was not stereospecific since the Ki values of both isomers of phospholactate and of phosphoglycolate were equal (370 µm) and larger than the Km of 2-phosphoglycerate (6.7 µm). Equal affinities for the analogues were confirmed by direct binding studies, but unequal ternary enhancements were observed for the substrate phosphoenolpyruvate (egrt = 3.7), d-phospholactate (egrt = 11.6), phosphoglycolate (egrt = 8.4), and l-phospholactate (egrt = 5.8) because of structural differences in their respective ternary complexes. Phosphoenolpyruvate carboxykinase, which catalyzes a reaction with a mechanism homologous with that of pyruvate kinase, shows the opposite inhibition pattern since it is preferentially inhibited by l-phospholactate (Ki = 28 µm) as compared with d-phospholactate (Ki = 292 µm). None of the analogues inhibited the reaction catalyzed by phosphoenolpyruvate synthetase. The patterns of inhibition by the phospholactates of pyruvate kinase (d >> l), enolase (d = l), and carboxykinase (l >> d) are explained in terms of the known stereochemistries of the reactions catalyzed by these enzymes and the structures at their respective active sites.

Submitted on June 17, 1970


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1970 by the American Society for Biochemistry and Molecular Biology.